33 results:
21. Clinical efficacy in dementia  
Clinical efficacy and patient benefits To date, more than 3000 patients have been included in clinical trials evaluating the efficacy of Cerebrolysin in Alzheimer's disease and vascular dementia.…  
22. Dementia  
Disease Dementia is the loss of cognitive performance to such an extent that it interferes with a person In the treatment of dementia, early diagnosis is one of the key issues but the diagnosis…  
23. Videos  
Video presentation about CARS studyCARS video Over the last decades, therapeutic approaches for stroke have significantly evolved. Implementation of modern stroke units, better general medical…  
24. Video and booklet with excersises  
Neurorehabilitation after stroke This page includes some information that is intended for registered users only. If you would like to access this information please login.Trailer…  
25. Expert Interviews  
Expert interview CARSInterview with Chief Investigator of CARS For the fist time a combination treatment in early rehabilitation after stroke has been tested positively! Learn more about the…  
26. Clinical efficacy in stroke  
Clinical efficacy and patient benefits Treatment of stroke with Cerebrolysin helps to regain independence. Its efficacy has been proven in 36 double-blind-studies and trials with more than 5.000…  
27. Stroke  
DiseaseStroke has become the second leading cause of long-term disability and the second cause of death worldwide.1 Annually, 15 million people suffer a stroke. Of these, 5 million die and…  
28. FAQ  
Frequently asked questions Cerebrolysin  
29. Prescribing Information  
Prescribing Information CerebrolysinAbbreviated Prescribing Information - Cerebrolysin Name of the medicinal product:  Cerebrolysin - Solution for injection. …  
30. Mode of Action  
Mode of Action of Cerebrolysin Cerebrolysin is a neurotrophic peptidergic drug with multimodal pharmacological properties indicated for the treatment of acute and chronic CNS disorders. The…  

Search results 21 until 30 of 33